Список литературы

  1. Gullotta F. Metabolic myopathies. //Pathol-Res-Pract. 1985Jul; 180(1): 10-8. Atkin J., Snow J.W., Zellweger H., Rhead W.J. Fatal infantile cardiac glycogenosis without acid maltase deficiency presenting as congenital hydrops [letter] //Eur-J-Pediatr. 1984 Jun; 142(2): 150.
  2. Hwang B., Meng C.C., Lin C.Y., Hsu H.C. Clinical analysis of five infants with glycogen storage disease of the heart-Pompe's disease. //Jpn-Heart-J. 1986 Jan; 27(1): 25-34.
  3. Van-Maldergem L., Haumont D., Saurty D., et al. Bradycardia in a case of type II glycogenosis (Pompe's disease) revealing in early neonatal period. //Acta-Clin-Belg. 1990; 45(6): 412-4.
  4. Alday L.E., Moreyra E. Secondary hypertrophic cardiomyopathy in infancy and childhood. //Am-Heart-J. 1984 Oct; 108(4 Pt 1):996-1000.
  5. Ullrich K., Grobe H., Korinthenberg R., von-Bassewitz D.B.Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia. //Pathol-Res-Pract. 1986 Oct; 181(5): 627-32.
  6. Wiegand V., Rumpf K., Bardosi A., et al. Hamodynamische Befunde bei der adulten Form der Glykogenose Typ II. //Z-Kardiol. 1986 Jan; 75(1): 44-6.
  7. Budde-Steffen C., Gravinghoff L., Albani M., et al. Nachtliche Heimbeatmung bei juvenilem Morbus Pompe mit pulmonalem Hypertonus und Rechtsherzinsuffizienz. //Dtsch-Med-Wochenschr. 1989Jul 14; 114(28-29): 1114-6.
  8. Miyamoto Y., Etoh Y., Joh R., et al. Adult-onset acid maltase deficiency in siblings.// Acta-Pathol-Jpn. 1985 Nov; 35(6):1533-42.
  9. Fung K.P., Lo R.N., Ho H.C. Pompe's disease presenting as supraventricular tachycardia. Department of Paediatrics, National University of Singapore.// Aust- Paediatr-J. 1989 Apr; 25(2):101-2.
  10. О.М.Елисеев. Поражения сердечно-сосудистой системы при обменных заболеваниях. Болезни сердца и сосудов. под ред. Е.И. Чазова. 1992., Том 4 стр. 180-215.
  11. De-Dominicis E., Finocchi G., Vincenzi M., et al. Echocardiographic and pulsed Doppler features in glycogen storage disease type II of the heart (Pompe's disease). //Acta-Cardiol. 1991;46(1): 107-14.
  12. Shapir Y., Roguin N. Echocardiographic findings in Pompe's disease with left ventricular obstruction. //Clin-Cardiol. 1985 Mar; 8(3): 181-5.
  13. Boxerm R.A., Fishman M., LaCorte M.A., et al. Cardiac MR imaging in Pompe disease. //J-Comput-Assist-Tomogr. 1986 Sep-Oct; 10(5): 857-9.
  14. Coleman R.A., Winter H.S., Wolf B., et al. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.// Ann-Intern-Med. 1992 Jun 1; 116(11): 896-900.
  15. Olson L.J., Reeder G.S., Noller K.L., et al. Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy.// Am-J-Cardiol. 1984 Mar 15; 53(7): 980-1.
  16. Moses S.W., Wanderman K.L. Myroz A., et al. Cardiac involvement in glycogen storage disease type III.// Eur-J-Pediatr. 1989 Aug; 148(8): 764-6.
  17. Servidei S., Riepe R.E., Langston C., et al. Severe cardiopathy in branching enzyme deficiency.// J-Pediatr. 1987 Jul;111(1): 51-6.
  18. Labrune P., Huguet P., Odievre M. Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients. //Pediatr-Cardiol. 1991 Jul; 12(3): 161-3.
  19. Е.Л.Розенфельд, И.А.Попова // Гликогеновая болезнь М.,Медицина, 1979, 288 с.
  20. Tunon T., Bengoechea O., Narbona J. Glycogenosis with amylopectinoid deposits in a 13-year-old girl.// Clin-Neuropathol. 1988 May-Jun; 7(3): 100-4.
  21. Greene G.M., Weldon D.C., Ferrans V.J. Juvenile polysaccharidosis with cardioskeletal myopathy.// Arch-Pathol-Lab-Med. 1987 Oct; 111(10): 977-82. Eishi Y., Takemura T., Sone R., et al. Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: a new type of glycogen storage disease. Hum-Pathol. 1985 Feb; 16(2): 193-7.
  22. Byrne E., Dennett X., Crotty B., et al. Dominantly inherited cardioskeletal myopathy with lysosomal glycogen storage and normal acid maltase levels. Brain. 1986 Jun; 109 ( Pt 3): 523-36.
  23. Bru Р., Pellissier J.F., Gatau-Pelanchon J., et al. Glycogenose lysosomiale cardio-musculaire de l'adulte sans deficit enzymatique connu. Cause de myocardiopathie familiale et surcharge lysosomiale en glycogene avec maltase acide normale. Arch-Mal-Coeur-Vaiss. 1988 Jan; 81(1): 109-14.
  24. Tamura S., Takahashi M., Kawamura S., Ishihara T. Basophilic degeneration of the myocardium: Histological, immunohistochemical and immuno-electronmicroscopic studies //Histopathology. 1995, 26/6, 501-508.
  25. Benvenuti L.A., De-Lourdes-Higuchi-M., Demarchi-Aiello-V. Et al. Myocardial ANP expression in Pompe's disease: An immunohistochemical study //Cardiovasc- pathol. 1994, 3/4, 277-280.
  26. De-La-Blanchardiere-A., Vayssier C., Duboc D., et al. Severe cardiomyopathy revealing type IV glycogen storage disease in two sibs //Presse-med.1994, 23/24, 1124- 1127.
  27. Dworzak F., Casazza F., Mora M., et al. Lysosomal glycogen storage with normal acid maltase: A familial study with successful heart transplant. //neuromuscular- disord., 1994, 4/3,243-247.
  28. Elleder M., Shin Y.S., Zuntova A., et al. Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase. //Virchows-arch-a-pathol-anat-histopathol.,1993, 423/4, 303-307.
  29. Carvalho J.S., Matthews E.E., Leonard J.V., Deanfield J. Cardiomyopathy of glycogen storage disease type III. //Heart-vessels., 1993, 8/3,155-159.
  30. Schmitz G., Hohage H., Ullrich K. Glucose-6-phosphate: A key compound in glycogenosis I and favism leading to hyper- or hypolipidaemia //Eur-j-pediatr.,1993, 152/SUPPL. 1, S77-S84.
  31. Masuda H; Morishita Y; Taira A; Kuriyama M. Aortic stenosis associated with Scheie's syndrome. Report of successful valve replacement.Chest. 1993 Mar; 103(3): 968-70
  32. Muenzer J.; Beekman R. H.; Profera L. M.; Bove E.L. Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome).SO: Pediatr- Cardiol. 1993 Mar; 14(2): 130-2
  33. Marwick T.H.; Bastian B.; Hughes CF.; Bailey B.P. Mitral stenosis in the Maroteaux-Lamy syndrome: a treatable cause of dyspnoea. Postgrad-Med-J. 1992 Apr; 68(798): 287-8.
  34. Tan C.T.; Schaff H.V.; Miller F.A.Jr.; Edwards W.D.; Karnes P.S. Valvular heart disease in four patients with Maroteaux-Lamy syndrome. Circulation. 1992 Jan; 85(1): 188-95.
  35. Nelson J., Shields M.D., Mulholland H.C. Cardiovascular studies in the mucopolysaccharidoses.// J-Med-Genet. 1990 Feb; 27(2): 94-100.
  36. Taylor J., Thorner P., Geary D.F. et al. Nephrotic syndrome and hypertension in two children with Hurler syndrome.// J-Pediatr. 1986 May; 108(5 Pt 1): 726-9.
  37. Taylor D.B., Blaser S.I., Burrows P.E., et al. Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings.// AJR- Am-J-Roentgenol. 1991 Oct; 157(4): 819-23.
  38. С.И.Козлова, Е.Семанова, Н.С.Демикова, О.Е.Блинникова. Наследственные синдромы и медикогенетическое консультирование.Л., Медицина, 1987,- 320 с.
  39. Ata J., Brigui M., Jerad T., et al. L'atteinte cardiaque dans la mucopolysaccharidose. A propos d'une etude echocardiographique de huit cas.// Ann- Pediatr-Paris. 1991 Nov; 38(9): 614-7.
  40. Herranz-Jordan B., Campo-Sampedro F., Pedrola-Guixe D., et al. Mucopolisacardosis tipo III A en una nina con comunicacion interauricular y crisis de taquicardia paroxistica supraventricular.// An-Esp-Pediatr. 1990 Jan; 32(1): 85-7.
  41. John R.M., Hunter D., Swanton R.H. Echocardiographic abnormalities in type IV mucopolysaccharidosis.// Arch-Dis-Child. 1990 Jul; 65(7): 746-9.
  42. Auzepy P., Papa F., Quillard J., et al. Syndrome de Uhlde l'adulte et dysplasie spondyloepiphysaire// Arch-Anat-Pathol-Paris. 1975 Mar; 23(1): 73-7.
  43. Betremieux P., Lefrancois C., Guerin M.N., et al. Insuffisance cardiaque aigue chez une fillette atteinte de maladie de Maroteaux-Lamy. Evolution favorable sous traitement. // Ann-Pediatr-Paris. 1985 Sep; 32(7): 639-41.
  44. Leung A.K., Robson W.L. Mongolian spots and GM1 gangliosidosis type one [letter] //J-R-Soc-Med. 1993 Feb; 86(2): 120-1.
  45. Uyama E.,Terasaki T., Watanabe S., et al. Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. //Acta-Neurol-Scand. 1992 Dec; 86(6): 609-15.
  46. Simma B.,Sperl W., Hammerer I. GM1 Gangliosidose und dilatative Cardiomyopathie. //Klin-Padiatr. 1990 May-Jun; 202(3): 183-5.
  47. Hurowitz G.I.Silver J.M. Brin M.F., et al. Neuropsychiatric aspects of adult- onset Tay-Sachs disease: two case reports with several new findings. //J- Neuropsychiatry-Clin-Neurosci. 1993 Winter; 5(1): 30-6.
  48. Fukumizu M.,Yoshikawa H., Takashima S., et al. Tay-Sachs disease: progression of changes on neuroimaging in four cases. //Neuroradiology. 1992; 34(6): 483-6.
  49. Bolhuis P.A.,Bikker H. Deletion of the 5'-region in one or two alleles of HEXB in 15 out of 30 patients with Sandhoff disease [letter] //Hum-Genet. 1992 Nov; 90(3): 328-9.
  50. Okada S; Owada M; Sakiyama T; Yutaka T; Ogawa M. I-cell disease: clinical studies of 21 Japanese cases. Clin-Genet. 1985 Sep; 28(3): 207-15.
  51. Sakura N; Hayashida M; Waki C; Kobayashi M; Tanimoto T. Asymmetric ventricular septal hypertrophy in I-cell disease. J-Inherit-Metab-Dis. 1986; 9(4): 401-2.
  52. Mutoh T., Senda Y., Sugimura K., et al. Severe orthostatic hypotension in a female carrier of Fabry's disease. Arch-Neurol. 1988 Apr; 45(4): 468-72.
  53. Paira S.O., Roverano S., Iribas J.L., Barcelo H.A. Joint manifestations of Fabry's disease. Clin-Rheumatol. 1992 Dec;11(4): 562-5
  54. Tanaka H.,Adachi K., Yamashita Y., et al. Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy. J-Cardiol.1988 Sep; 18(3): 705-18.
  55. Yokoyama A., Yamazoe M., Shibata A. A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves. Br-Heart-J. 1987; 57(3): 296-9.
  56. Kramer W., Thormann J., Mueller K., Frenzel H. Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation. Int-J- Cardiol. 1985 Jan; 7(1): 72-5.
  57. Iwase M., Yamauchi K., Maeda M., et al. Echocardiographic findings in a case of Fabry's disease with aortic regurgitation and complete AV block, and in his family members. J-Cardiol. 1988 Jun; 18(2): 589-98.
  58. Tsuda T., Yokoyama A., Masani F., et al. Myocardial involvement in female Fabry's disease: evaluation by thallium-201 myocardial scintigraphy. J-Cardiol. 1988 Mar; 18(1): 135-44.
  59. Sakuraba H., Yanagawa Y., Igarashi T., et al. Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes. Clin-Genet. 1986 Apr; 29(4): 276-83.
  60. Ikari Y., Kuwako K., Yamaguchi T. Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system. Br-Heart-J. 1992 Sep; 68(3):323-5.
  61. Suzuki M., Goto T., Kato R., et al. Combined atrioventricular block and sinus node dysfunction in Fabry's disease. Am-Heart-J. 1990 Aug; 120 (2): 438-40. Sivaloganathan S. Fabry's disease –a rare cause of sudden death. Med-Sci-Law. 1992 Jul; 32(3): 263-6.
  62. Yoshida K., Murase M., Maseki T., et al. Transvenous permanent pacemaker implantation for Fabry's disease. 3 cases report. Nippon-Kyobu-Geka-Gakkai-Zasshi. 1989 Feb; 37(2): 386-90.
  63. Santavy J., Santava A., Simek I., et al. Soucasne moznosti prenatalni diagnostiky Fabryho choroby. Cesk-Pediatr. 1992 Nov; 47(11): 641-4.
  64. Sakuraba H., Igarashi T., Shibata T., Suzuki Y. Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease. Clin-Genet. 1987 May; 31(5): 349-54.
  65. Sidransky E., Ginns E.I. Clinical heterogeneity among patients with Gaucher's disease [clinical conference] // JAMA. 1993 Mar 3; 269(9): 1154-7.
  66. Sidransky E., Sherer D.M., Ginns E.I. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.// Pediatr-Res. 1992 Oct; 32(4): 494-8.
  67. Maaswinkel-Mooij P.D., Kerstjens-Frederikse W.S. de-Koning J., et al. Gaucher's disease in childhood: presentation and treatment.// Tijdschr-Kindergeneeskd. 1992 Dec; 60(6): 231-5.
  68. Zimran A., Kay A., Gelbart T., et al. Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.//Medicine-Baltimore. 1992 Nov; 71(6): 337-53.
  69. Henderson J.M., Gilinsky N.H., Lee E.Y., Greenwood M.F. Gaucher's disease complicated by bleeding esophageal varices and colonic infiltration by Gaucher cells. // Am-J-Gastroenterol. 1991 Mar; 86(3): 346-8.
  70. Wilson E.R., Barton N.W., Barranger J.A. Vascular involvement in type 3 neuronopathic Gaucher's disease.// Arch-Pathol-Lab-Med. 1985 Jan; 109(1): 82-4.
  71. Uyama E., Takahashi K., Owada M., et al. Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with - glucocerebrosidase deficiency and a mosaic population of storage cells.// Acta-Neurol-Scand. 1992 Oct; 86(4): 407-20.
  72. Gonzalez-de-Dios J., Jara-Vega P., Diaz-Fernandez M.C., et al. Cardiovascular calcifications in Gaucher disease.// An-Esp-Pediatr. 1993 Feb; 38(2): 178-80.
  73. Mistry P.K., Davies S., Corfield A., et al. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.// Q-J-Med. 1992 Jul; 83(303): 541-6.
  74. Orecchia L; Signorile G; Pezzano A; et al. La malattia di Niemann-Pick di tipo C in gemelle monocoriali. Minerva-Pediatr. 1992 Oct; 44(10): 491-5.
  75. Patterson M.C; DiBisceglie A.M; Higgins J.J; et-al The effect of cholesterol- lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology. 1993 Jan; 43(1): 61-4.
  76. Caruso R; Carl J.B; Fitzgibbon.EJ; Barton N.W; Katz N.N Ophthalmologic manifestations of type B Niemann-Pick diseases.
  77. Filling-Katz M.R; Fink J,K; Gorin M.B; et al. Metab-Pediatr-Syst-Ophthalmol. 1992; 15(1-3): 16-20
  78. Schafer-IA; Farquhar-L; Weber-FL Jr; Mayes-JT; Schulak-JA; Petrelli-M; Zirzow-GC; et-al Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic disease. Hepatology. 1993 Jan; 17(1): 42-9.
  79. Hulette C.M; Earl N.L; Anthony D.C; Crain B.J. Adult onset Niemann-Pick disease type C presenting with dementia and absent organomegaly.Clin-Neuropathol. 1992 Nov-Dec; 11(6): 293-7.
  80. Higgins J.J.; Patterson M.C.; Dambrosia JM; et al.A clinical staging classification for type C Niemann-Pick disease. Neurology. 1992 Dec; 42(12): 2286-90.
  81. Bembi B.; Comelli M.; Scaggiante B.; et al. Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells. Am-J-Med-Genet. 1992 Nov 1; 44(4): 527-33
  82. Westwood M. Endocardial fibroelastosis and Niemann-Pick disease //Br.Yeart J.1977, 39, 1394
  83. Brady R.O. Sphingomyelin lipidosis: Niemann-Pick disease. In The metabolic Basis of Inherited Disease. Ed by J.B. Stanbury et al. New York, 1983.

[Возврат]